U.S. clinicians slow to adopt new, safer direct oral anticoagulants

Despite evidence favoring direct oral anticoagulants over the drug Warfarin, adoption in U.S. clinical practice has been slow, a new Yale study finds.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news